SLC9C1 and ischemia: As the NHE inhibitor was administered after the ischemic event, it would not be able to block the increase in cytosolic Na+ and Ca2+ that occurs during ischemia and therefore would not prevent Ca2+-mediated initiation of necrotic cell death.